SURGICAL CONSIDERATIONS IN THE IMMUNOCOMPROMISED CANCER PATIENT NLM AIDSLINE Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


SURGICAL CONSIDERATIONS IN THE IMMUNOCOMPROMISED CANCER PATIENT

Fundamentals of Surgical Oncology. McKenna RJ, Murphy GP, eds. New York, Macmillan Publishing Company, p. 114-40, 1986.. Unique Identifier : AIDSLINE ICDB/87638736
Bodey GP; McKenna RJ Jr; Univ. of Texas, Houston, TX


Abstract: The immunocompromised cancer patient (pt) presents unique challenges in diagnosis and therapy. Increasingly, the surgeon is called upon to intervene in immunocompromised pts to assist in the diagnosis of infectious complications or in the therapy of the disease process. This has resulted from the lower risks of surgical procedures, improved postoperative care, the difficulty in diagnosing obscure infectious diseases, and the availability of effective therapy for many previously untreatable disorders. Consequently, the surgeon must be familiar with the special problems of these pts in order to provide optimum care. Surgical considerations in the immunocompromised cancer pt are discussed under the following headings: host factors predisposing to infection, acute abdomen, other abdominal diseases, splenectomy, perianal infections, surgical approach to aspergillosis and phycomycosis, skin infections, extravasation of vesicant drugs, CNS complications, intravascular catheters, thrombocytopenia and platelet transfusion, antibiotic therapy and hemorrhage, role of granulocyte transfusions, acquired immunodeficiency syndrome, open lung biopsy, and risks to the surgeon. (87 Refs)
Keywords: Abdomen, Acute/SURGERY Acquired Immunodeficiency Syndrome/IMMUNOLOGY Antineoplastic Agents/ADVERSE EFFECTS Bacterial Infections/IMMUNOLOGY Catheters, Indwelling Human Immune Tolerance Mycoses/IMMUNOLOGY Neoplasms/IMMUNOLOGY/*SURGERY Risk Splenectomy Surgical Wound Infection/*IMMUNOLOGY/THERAPY MONOGRAPH

KWDabdomen,acute/surgeryacquiredimmunodeficiencysyndrome/immunologyantineoplasticagents/adverseeffectsbacterialinfections/immunologycatheters,indwellinghumanimmunetolerancemycoses/immunologyneoplasms/immunology/KWDsurgeryrisksplenectomysurgicalwoundinfection/KWDimmunology/therapymonograph
880130
M8810370


Copyright © 1988 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .